5 withdrawn. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Withdrawn 5 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Abnormalities, Multiple: new trials by email Literature Review of Abnormalities, Multiple trials Research Report on Abnormalities, Multiple
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome RAD011 - Prader-Willi Syndrome | Phase 3 | Withdrawn | Radius Pharmaceuticals, Inc. | 2023-01-01 | 2022-10-06 | |
| A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) Tolvaptan (OPC-41061) - Autosomal Recessive Polycystic Kidney Disease (ARPKD) | Phase 3 | Withdrawn | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-07-01 | 2025-12-24 | |
| An Open-Label Study of DCCR Tablet in Patients With PWS DCCR - Prader-Willi Syndrome | Phase 3 | Withdrawn | Soleno Therapeutics, Inc. | 2019-10-01 | 2021-08-03 | |
| Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome Blood draw - Marfan Syndrome | Phase 3 | Withdrawn | Ann & Robert H Lurie Children's Hospital of Chicago | 2011-04-01 | 2016-02-05 | |
| Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) LDE225B, Vehicle - Basal Cell Carcinoma | Phase 2 / Phase 3 | Withdrawn | Novartis Pharmaceuticals | 2017-05-05 |
Prader-Willi Syndrome (2) · Basal Cell Nevus Syndrome (1) · Carcinoma, Basal Cell (1) · Marfan Syndrome (1) · Oligohydramnios (1) · Polycystic Kidney Diseases (1) · Polycystic Kidney, Autosomal Recessive (1)
Congenital Abnormalities (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Genetic Diseases, Inborn (5) · Bone Diseases (2) · Bone Diseases, Developmental (2) · Chromosome Disorders (2) · Imprinting Disorders (2) · Intellectual Disability (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Nutrition Disorders (2) · Nutritional and Metabolic Diseases (2)
Blood Specimen Collection (1) · Tolvaptan (1)
Ann & Robert H Lurie Children's Hospital of Chicago (1) · Novartis Pharmaceuticals (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1) · Radius Pharmaceuticals, Inc. (1) · Soleno Therapeutics, Inc. (1)
Belgium (1) · Canada (1) · Czechia (1) · Finland (1) · Germany (1) · Greece (1) · Italy (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)